Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07225179 · ClinicalTrials.gov registry record · NA
mHealth for Early Psychosis Caregivers in Statewide Program Outreach
A NA study of Caregiver and Family Caregivers, sponsored by University of North Carolina, Chapel Hill.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT07225179: Recruiting NA study of Caregiver and Family Caregivers, sponsored by University of North Carolina, Chapel Hill.
NCT07225179 is a NA study of Caregiver and Family Caregivers that is actively recruiting participants, run by University of North Carolina, Chapel Hill. The registered enrollment target is 30 participants, below the 1,255-participant average among 20 other Caregiver trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07225179, a NA study of Caregiver and Family Caregivers, is actively recruiting participants, sponsored by University of North Carolina, Chapel Hill.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to pilot the delivery of an mHealth intervention for caregivers to young people with early psychosis within a network of early psychosis intervention programs in the state of North Carolina. The investigators will examine the feasibility of recruitment through program outreach, develop North Carolina specific outreach resources to be used with the mHealth intervention and evaluate the effectiveness of this intervention for reducing caregiver psychological morbidity and improving family communication. The investigators will also collect pilot data to inform recruitment and development of implementation strategies for delivering Bolster within a statewide early psychosis network.
Primary Outcome
Family communication will be assessed with the Family Questionnaire (FQ). The FQ is a 20-item self-report assessment of criticism and emotional expression in interactions with family members toward patients with mental illness. Each item is rated on a 4-point scale (1 = never/very rarely; 4 = very often). The FQ is scored by summing individual items with higher scores indicating greater levels of expressed emotion. As a primary outcome, the investigators will examine the combined total of emotio
Conditions Studied
Interventions
- BEHAVIORAL Bolster
Study Locations (1)
North Carolina
- UNC Department of Psychiatry - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-12-01 |
| Est. Completion | 2026-07-30 |
| Phase | NA |
What NCT07225179 shows while recruiting
NCT07225179 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,255-participant average among 20 other Caregiver trials with a reported enrollment target (98% lower).
The record links to 4 conditions, with Caregiver appearing as the primary indexed condition, and to 1 intervention - of which Bolster is the first listed.
NCT07225179 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT07225179 about?
NCT07225179 is a clinical study titled "mHealth for Early Psychosis Caregivers in Statewide Program Outreach". The purpose of this study is to pilot the delivery of an mHealth intervention for caregivers to young people with early psychosis within a network of early psychosis intervention programs in the state of North Carolina. The investigators will examine the feasibility of recruitment through program ou...
What is the current status of trial NCT07225179?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-12-01. Estimated completion is 2026-07-30.
What conditions does trial NCT07225179 study?
This clinical trial studies the following conditions: Caregiver, Family Caregivers, Caregiver Distress, Caregiver to a Young Adult With Early Psychosis.
What interventions are being tested in trial NCT07225179?
The interventions under investigation include: Bolster (BEHAVIORAL).
Who is sponsoring clinical trial NCT07225179?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07225179 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Caregiver
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07225179's enrollment target sits among peer trials
30 19th of 20 higher than 2 of 20 other Caregiver trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Caregiver trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Behavioral Health Program for Short-Stay Nursing Facility Residents & Care Partners
RECRUITING · NA
-
Support for Bereaved Cancer Caregivers
RECRUITING · NA
-
The REACH Intervention for Caregivers of Veterans and Service Members With TBI
RECRUITING · NA
-
FearLess in NeuroOncology
RECRUITING · NA
-
Multimedia Self-Management Intervention for Lung Cancer Surgery Family Caregivers and Patients
ACTIVE NOT RECRUITING · NA
-
Preference of Room Setting and Waiting Time in Patients With Advanced, Locally Advanced, or Metastatic Cancer and Their Caregivers Who Are Seen in the Outpatient Supportive/Palliative Care Center
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI